摘要
["BACKGROUND AND PURPOSE We and others have shown that inhibiting phosphatase and tensin homolog deleted on chromosome 10 (PTEN) or activating ERK1/ 2 confer neuroprotection. As bisperoxovanadium compounds are well-established inhibitors of PTEN, we designed bisperoxovandium (pyridin-2-squaramide) [ bpV(pis)] and determined whether and how bpV(pis) exerts a neuroprotective effect in cerebral ischaemia-reperfusion injury.","EXPERIMENTAL APPROACH Malachite green-based phosphatase assay was used to measure PTEN activity. A western blot assay was used to measure the phosphorylation level of Akt and ERK1/ 2 (p-Akt and p-ERK1/ 2). Oxygen-glucose deprivation (OGD) was used to injure cultured cortical neurons. Cell death and viability were assessed by LDH and MTT assays. To verify the effects of bpV(pis) in vivo, Sprague-Dawley rats were subjected to middle cerebral artery occlusion, and brain infarct volume was measured and neurological function tests performed.","KEY RESULTS bpV(pis) inhibited PTEN activity and increased p-Akt in SH-SY5Y cells but not in PTEN-deleted U251 cells. bpV(pis) also elevated p-ERK1/ 2 in both SH-SY5Y and U251 cells. These data indicate that bpV(pis) enhances Akt activation through PTEN inhibition but increases ERK1/ 2 activation independently of PTEN signalling. bpV(pis) prevented OGD-induced neuronal death in vitro and reduced brain infarct volume and promoted functional recovery in stroke animals. This neuroprotective effect of bpV(pis) was blocked by inhibiting Akt and/ or ERK1/ 2.","CONCLUSIONS AND IMPLICATIONS bpV(pis) confers neuroprotection in OGD-induced injury in vitro and in cerebral ischaemia in vivo by suppressing PTEN and activating ERK1/ 2. Thus, bpV(pis) is a bi-target neuroprotectant that may be developed as a drug candidate for stroke treatment."]
| 源语言 | 英语 |
|---|---|
| 页(从-至) | 641-656 |
| 页数 | 16 |
| 期刊 | British Journal of Pharmacology |
| 卷 | 174 |
| 期 | 8 |
| DOI | |
| 出版状态 | 已出版 - 4月 2017 |
基金资助
This work was supported by China Key Project of Basic Research ('973' Project; 2014CB541606), Natural Science Foundation of China (NSFC; 81470599) and Fund of Collaborative Innovation Center for Brain Science to Q.W.
联合国可持续发展目标
此成果有助于实现下列可持续发展目标:
-
可持续发展目标 3 良好健康与福祉
关键词
- Animals
- Brain Ischemia
- Cell Death
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Enzyme Inhibitors
- Glucose
- Humans
- Mitogen-Activated Protein Kinase 1
- Mitogen-Activated Protein Kinase 3
- Neurons
- Neuroprotective Agents
- Oxygen
- PTEN Phosphohydrolase
- Rats
- Rats, Sprague-Dawley
- Structure-Activity Relationship
- Tumor Cells, Cultured
- Vanadium Compounds
- bisperoxovanadium
- lactate dehydrogenase
- mitogen activated protein kinase 1
- neuroprotective agent
- phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase
- unclassified drug
- enzyme inhibitor
- glucose
- mitogen activated protein kinase 3
- oxygen
- PTEN protein, human
- vanadium derivative
- animal experiment
- animal model
- Article
- brain cell
- brain infarction size
- brain ischemia
- cell death
- cell viability
- drug efficacy
- drug mechanism
- drug response
- drug targeting
- enzyme activity
- enzyme inhibition
- human
- human cell
- IC50
- male
- middle cerebral artery occlusion
- neuroprotection
- nonhuman
- protein phosphorylation
- rat
- treatment outcome
- animal
- chemistry
- disease model
- dose response
- drug effects
- metabolism
- nerve cell
- pathology
- Sprague Dawley rat
- structure activity relation
- synthesis
- tumor cell culture
收录
- Scopus
- SCIE
学术指纹
探究 'Bisperoxovandium (pyridin-2-squaramide) targets both PTEN and ERK1/2 to confer neuroprotection' 的科研主题。它们共同构成独一无二的学术指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver